Three-Year Overall Survival With Nivolumab Plus Relatlimab in Advanced Melanoma From RELATIVITY-047
Bristol-Myers Squibb
Hussein A Tawbi; F Stephen Hodi; Evan J Lipson; Dirk Schadendorf; Paolo A Ascierto; Luis Matamala; Erika Castillo Gutiérrez; Piotr Rutkowski; Helen Gogas; Christopher D Lao; Juliana Janoski De Menezes; Stéphane Dalle; Ana Maria Arance; Jean-Jacques Grob; Barbara Ratto; Saima Rodriguez; Antonella Mazzei; Sonia Dolfi; Georgina V Long